DUCHIN; Kenneth L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DUCHIN; Kenneth L..The latest application filed is for "methods for the treatment of overactive bladder".

Company Profile

0.13.28

DUCHIN; Kenneth L. - Delray Beach FL
Duchin; Kenneth L. - Fort Lauderdale FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For The Treatment Of Overactive Bladder App 20170258767 - PABORJI; Mehdi ; et al.	2017-09-14
Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder Grant 9,744,157 - Paborji , et al. August 29, 2	2017-08-29
Combinations Of Solifenacin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20160213650 - Paborji; Mehdi ; et al.	2016-07-28
Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder Grant 9,132,124 - Paborji , et al. September 15, 2	2015-09-15
Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder Grant 8,940,763 - Paborji , et al. January 27, 2	2015-01-27
Combinations Of Trospium And Salivary Stimulants For The Treatment Of Overactive Bladder App 20140194454 - PABORJI; Mehdi ; et al.	2014-07-10
Methods For The Treatment Of Overactive Bladder App 20130296392 - PABORJI; Mehdi ; et al.	2013-11-07
Combinations Of Trospium And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289539 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Oxybutynin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289568 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Imidafenacin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289563 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Trospium And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289529 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Darifenacin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289567 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Darifenacin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289562 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Solifenacin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289543 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Trospium And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289531 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Tolterodine And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289560 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Fesoterodine And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289561 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Tolterodine And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289565 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Solifenacin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289544 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Fesoterodine And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289566 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Trospium And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289530 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Oxybutynin And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289564 - PABORJI; Mehdi ; et al.	2012-11-15
Combinations Of Propiverine And Salivary Stimulants For The Treatment Of Overactive Bladder App 20120289547 - PABORJI; Mehdi ; et al.	2012-11-15
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20070060635 - Broder; Samuel ; et al.	2007-03-15
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 7,041,640 - Broder , et al. May 9, 2	2006-05-09
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20050238634 - Broder, Samuel ; et al.	2005-10-27
Method and compositions for administering taxanes orally to human patients Grant 6,936,583 - Broder , et al. August 30, 2	2005-08-30
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 6,818,615 - Broder , et al. November 16, 2	2004-11-16
Method, compositions and kits for increasing the oral bioavailability or pharmaceutical agents App 20040176439 - Broder, Samuel ; et al.	2004-09-09
Method and compositions for administering taxanes orally to human patients App 20040171532 - Broder, Samuel ; et al.	2004-09-02
Method and compositions for administering taxanes orally to human patients Grant 6,730,698 - Broder , et al. May 4, 2	2004-05-04
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 6,610,735 - Broder , et al. August 26, 2	2003-08-26
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20030069301 - Broder, Samuel ; et al.	2003-04-10
Method and compositions for administering taxanes orally to human patients App 20020156125 - Broder, Samuel ; et al.	2002-10-24
Method and compositions for administering taxanes orally to human patients Grant 6,395,770 - Broder , et al. May 28, 2	2002-05-28
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20020058616 - Broder, Samuel ; et al.	2002-05-16
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 6,245,805 - Broder , et al. June 12, 2	2001-06-12
Method for increasing the oral bioactivity of pharmaceutical agents Grant 5,968,972 - Broder , et al. October 19, 1	1999-10-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.